Safety Shot, Inc., a wellness and functional beverage company, researches and develops over-the-counter products and intellectual property. The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content. It also develops Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; and NoStingz, a jellyfish sting prevention sunscreen. The company sells its products through distributors, retailers, and e-commerce websites. The company was formerly known as Jupiter Wellness, Inc. and changed its name to Safety Shot, Inc. in September 2023. Safety Shot, Inc. was incorporated in 2018 and is based in Jupiter, Florida.
Employees - 8,
CEO - Jarrett A. Boon,
Sector - Consumer Defensive,
Country - US,
Market Cap -
Altman ZScore(max is 10): -43.18, Piotroski Score(max is 10): 1, Working Capital: $-6816954, Total Assets: $7338403, Retained Earnings: $-115090347, EBIT: -48159722, Total Liabilities: $9511455, Revenue: $1173359
- Current Price $ - Analyst Target Price $Ticker | SHOT |
Index | |
Curent Price | |
Change | |
Market Cap | |
Average Volume | |
Income | |
Sales | |
Book Value/Share | |
Cash/Share | |
Dividend Est | |
Dividend TTM | |
Dividend Ex-Date | |
Employees | |
Moving Avg 20days | |
Moving Avg 50days | |
Moving Avg 200days | |
Shares Outstanding | |
Earnings Date | |
Inst. Ownership |
Price/Earnings | |
Forwad P/E | |
PE Growth | |
Price/Sales | |
Price/Book | |
Price/Cash | |
Price/FCF | |
Quick Ratio | |
Current Ratio | |
Debt/Equity | |
Return on Assets | |
Return on Equity | |
Return on Investment | |
Gross Margin | |
Ops Margin | |
Profit Margin | |
RSI | |
BETA(β) | |
From 52week Low | |
From 52week High |
EPS | |
EPS next Year | |
EPS next Qtr | |
EPS this Year | |
EPS next 5 Year | |
EPS past 5 Year | |
Sales past 5 Year | |
EPS Y/Y | |
Sales Y/Y | |
EPS Q/Q | |
Sales Q/Q | |
Sales Surprise | |
EPS Surprise | |
ATR(14) | |
Perf Week | |
Perf Month | |
Perf Quarter | |
Perf Year | |
Perf YTD | |
Target Price |
AryaFin Engine© - An AI FinTech Venture - 2024-25 Disclaimer